TIME TO REBOUND IN JOINT SYMPTOMS FOLLOWING DISCONTINUATION OF TNFI THERAPY AFTER ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN PSORIATIC ARTHRITIS PATIENTS ENROLLED IN THE US CORRONA REGISTRY

被引：0
|
作者：
Harrold, L. R. [1 ]
Stolshek, B. [2 ]
Rebello, S. [1 ]
Collier, D. [2 ]
Mutebi, A. [2 ]
Wade, S. W. [3 ]
Malley, W. [1 ]
Greenberg, J. D. [1 ]
Etzel, C. J. [1 ]
机构：
[1] Corrona LLC, Southborough, MA USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Wade Outcomes Res Consulting, Salt Lake City, UT USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.1324
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0423
引用
收藏
页码：342 / 343
页数：2
相关论文
共 34 条
  • [21] DIFFERENCES BETWEEN EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS IN TIME TO ACHIEVING CDAI BUT NOT FATIGUE LOW DISEASE ACTIVITY AND REMISSION: DATA FROM THE OBRI REGISTRY
    Pope, J.
    Movahedi, M.
    Rampakakis, E.
    Cesta, A.
    Sampalis, J.
    Bombardier, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 951 - 952
  • [22] COMPARISON OF PATIENTS (PTS) WITH RHEUMATOID ARTHRITIS (RA) AMONG DISEASE ACTIVITY CATEGORIES AFTER 6 MONTHS OF TREATMENT WITH A TUMOUR NECROSIS FACTOR INHIBITOR (TNFI): RESULTS FROM THE CORRONA® RA REGISTRY
    Kremer, J. M.
    Winkler, A.
    Anatale-Tardiff, L.
    Mclean, R.
    Shan, Y.
    Moore, P.
    Tundia, N.
    Suboticki, J.
    Tesser, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 625 - 625
  • [23] Calprotectin Serum Levels Reflect Residual Inflammatory Activity in Patients with Rheumatoid Arthritis and Psoriatic Arthritis on Clinical Remission or Low Disease Activity Undergoing TNF-Antagonists Therapy.
    Inciarte-Mundo, Jose
    Victoria Hernandez, M.
    Cabrera-Villalba, Sonia
    Ramirez, Julio
    Cuervo, Andrea
    Ruiz-Esquide, Virginia
    Gonzalez Navarro, Azucena
    Yaguee, Jordi
    Canete, Juan D.
    Sanmarti, Raimon
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1278 - S1279
  • [24] PROBABILITY AND IMPACT OF ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH APREMILAST: POOLED ANALYSIS OF THE PALACE 1-3 PHASE 3 TRIALS
    McInnes, I.
    Mease, P. J.
    Behrens, F.
    Orbai, A. -M.
    Brunori, M.
    Teng, L.
    Guerette, B.
    Smolen, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1588 - 1589
  • [25] PROGNOSTIC FACTORS ASSOCIATED WITH NON-REMISSION OR LOW DISEASE ACTIVITY STATUS AFTER 1 YEAR OF PSORIATIC ARTHRITIS PATIENTS TREATMENT IN REAL PRACTICE
    Loginova, E.
    Korotaeva, T.
    Gubar, E.
    Korsakova, Y.
    Glukhova, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 260 - 260
  • [26] Low rates of biologic-free clinical disease activity index remission maintenance after biologic disease-modifying anti-rheumatic drug discontinuation while in remission in a Japanese multicentre rheumatoid arthritis registry
    Yoshida, Kazuki
    Kishimoto, Mitsumasa
    Radner, Helga
    Matsui, Kazuo
    Okada, Masato
    Saeki, Yukihiko
    Solomon, Daniel H.
    Tohma, Shigeto
    RHEUMATOLOGY, 2016, 55 (02) : 286 - 290
  • [27] Unmet Criteria for Achieving Minimal and Very Low Disease Activity Among Patients with Psoriatic Arthritis Initiating Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs in the CorEvitas PsA/SpA Registry
    Ogdie, Alexis
    Song, Chao
    Middaugh, Nicole
    Marchese, Maya
    Eliot, Melissa
    Low, Robert
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1177 - 1180
  • [28] Attainment of Low Disease Activity Is Predictive of Maintenance of Disease Control upon Adalimumab Discontinuation for Two Years Following Combination Therapy in Japanese Patients with Early Rheumatoid Arthritis.
    Tanaka, Yoshiya
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Miyasaka, Nobuyuki
    Kawana, Katsuyoshi
    Hiramatsu, Katsutoshi
    Kuroki, Aki
    Takeuchi, Tsutomu
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1059 - S1059
  • [29] Low Patient Global Assessment of Disease Activity and Negative Rheumatoid Factor Are Strongly Associated with Likelihood of Maintaining Remission Following Tapering of Therapy in Patients with Rheumatoid Arthritis
    Curtis, Jeffrey
    Emery, Paul
    Haraoui, Boulos
    Kricorian, Greg
    Yen, Priscilla
    Collier, David
    Bykerk, Vivian
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2556 - 2558
  • [30] Baseline Expressions of Cellular microRNA-31 and microRNA-10a Predict Remission and Low Disease Activity in Patients with Early Rheumatoid Arthritis after Six and Twelve Months of Therapy
    Hruskova, Veronika
    Prajzlerova, Klara
    Komarc, Martin
    Vernerova, Lucia
    Mann, Herman F.
    Filkova, Maria
    Pavelka, Karel
    Vencovsky, Jiri
    Senolt, Ladislav
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
1234